Not applicableStudy completedNCT04630275What this trial is testingGonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-ObsWho this might be right forHypogonadism Lars Møller Pedersen 172
Testing effectiveness (Phase 2)Ended earlyNCT03093831What this trial is testingPhase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone LymphomaWho this might be right forLymphoma, B-Cell, Marginal Zone National Cancer Centre, Singapore 5
Not applicableLooking for participantsNCT04870437What this trial is testingImpact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.Who this might be right forKidney Transplantation University Hospital, Angers 30
Testing effectiveness (Phase 2)Study completedNCT04323657What this trial is testingTC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more TCR2 Therapeutics 6
Testing effectiveness (Phase 2)UnknownNCT05200312What this trial is testingA Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell LymphomaWho this might be right forNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 36
Not applicableStudy completedNCT00001119What this trial is testingEffects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 288
Very early researchActive Not RecruitingNCT04161248What this trial is testingPhase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell LymphomaWho this might be right forLymphoma, B-Cell Canadian Cancer Trials Group 40
Not applicableEnded earlyNCT00836043What this trial is testingSafety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Genzyme, a Sanofi Company 6
Testing effectiveness (Phase 2)Ended earlyNCT02592876What this trial is testingTreatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell LymphomaWho this might be right forLymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more Seagen Inc. 81
Early research (Phase 1)Study completedNCT03939026What this trial is testingSafety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular LymphomaWho this might be right forRelapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma Allogene Therapeutics 50
Very early researchLooking for participantsNCT04227015What this trial is testingCTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological MalignancyWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma He Huang 72
Not applicableNot Yet RecruitingNCT07636655What this trial is testingImmune Monitoring Following B-cell Depletion in ANCA-associated VasculitisWho this might be right forVasculitis Associated With Anti-neutrophil Cytoplasmic Antibodies Nantes University Hospital 120
Very early researchUnknownNCT06045585What this trial is testingJY231 Injection in the Treatment of Relapsed or Refractory B-cell LymphomaWho this might be right forRelapsed or Refractory B-cell Lymphoma Guangdong Second Provincial General Hospital 20
Early research (Phase 1)Study completedNCT04626843What this trial is testingIntermittent Fasting and CLL/SLLWho this might be right forNeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic+3 more Eleah Stringer 15
Early research (Phase 1)Study completedNCT00361049What this trial is testingDonor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantWho this might be right forCancer Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT04661943What this trial is testingMaintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Ou Bai, MD/PHD 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05624749What this trial is testingPhase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)Who this might be right forSystemic Lupus Erythematosus Novartis Pharmaceuticals 288
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07034508What this trial is testingA Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1Who this might be right forDLBCL - Diffuse Large B Cell Lymphoma Institute of Hematology & Blood Diseases Hospital, China 134
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552What this trial is testingEvaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02282358What this trial is testingStudy of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular LymphomaWho this might be right forLymphomaRelapsed and RefractoryDiffuse Large B-Cell Lymphoma and Follicular Lymphoma Memorial Sloan Kettering Cancer Center 7